Skip to main content

Table 3 Combined age distribution of oral facial neoplasms biopsy results l

From: Oral maxillofacial neoplasms in an East African population a 10 year retrospective study of 1863 cases using histopathological reports

Dx 0–10 11–20 21–30 31–40 41–50 51–60 61–70 71–80 81–90 91 + US mean Range
AME 2 36 54 33 14 11 3 1 - - 18 30.52 5–75
MYX 5 4 5 1 1 1 1 - - - 3 22.42 6–64
AMEF 1 1 1 1 - - - - - - - 27.67 15–38
AOT - 1 - - - - - - - - 1 * *
ODT - - 1 - - - - - - - - * *
ODF - 3 2 - - - - - - - - 19.80 14–25
MAME - - - 1 - - - - - - - * *
FIB 18 30 22 22 21 11 11 - - - 1 31.00 0.5–70
OF            2   
CF - 3 4 - - 1 - - - - 1 27.00 12–52
CHD - - 1 1 - 1 - - - - - 40.50 30–58
OST 2 2 4 - - - - - - - 1 21.60 8–41
OSS - 1 1 1 3 - - - - - 1 35.20 20–45
FIS 1 1 - 2 - - - - - - 1 26.00 6–40
CHS - 1 2 3 1 - - - - - 1 30.71 14–49
MYXS - - - - 1 - - - - - - * *
RCS - 1 - - - - - - - - - * *
BUR 341 35 2 - 1 - - - - - 3 7.21 2–45
NHL 2 5 1 1 2 2 4 - - - - 35.33 1.5–63
HLH - - - 1 - - - - - - - * *
CPL - - - 1 - - - - - - - * *
SCCa 1 2 18 28 56 78 51 20 4 2 23 * *
ACa 2 1 3 1 2 3 - 2 - - 3 54.50 18–80
UCa - - 2 4 5 3 2 2 - - 1 49.22 23–72
NPCa - - 1 - - - - - - - - * *
NKTca - - - - 1 - - - - - - * *
Vca - - 1 1 - 3 - - 1 - - 53.84 22–80
BCCa - - - - - 1 - - - - - * *
ADN 2 3 7 2 2 1 1 - - - 1 29.16 3.1–61
PLA 3 14 30 19 9 6 6 1 - - 4 32.58 5–71
MOA - - - - 1 - - - - - - * *
OCA - 3 - - - - - - - - - 19.00 17–20
ADCa - 2 6 6 4 9 2 3 - - - 46.78 18–80
ACCa - 3 2 1 6 4 1 1 - - 1 46.86 20–65
SGCa - - - - 1 2 - - - - - 52.50 47–60
MSCa - 1 - 2 1 - - - - - - 33.00 14–48
MECa - 2 1 1 2 2 - - - - 1 37.22 13–60
CaPLA - - - - - - - - - - 1 * *
HAP 1 2 - - - - - 1 - - - 28.50 7–80
KS 30 32 176 109 34 11 4 - - - 13 31.78 1.6–68
HAS - - - - - - - - - - 1 * *
GCM 4 - 1 - 1 - - - - - - 12.93 .06–49
LEI - 1 - - - - - - - - - * *
RHS 3 4 1 - 1 - - - - - - * *
LPH 6 2 1 - 1 - 2 - - - - 17.61 0.7–70
LPHS - - 1 - - - - - - - - * *
LIP 3 7 6 2 2 3 - - 2 - 4 33.30 1–88
LIS - - - 1 - 1 - - - - - 51.50 36–67
MEP 1 - - - - - - - - - - * *
MEL - - - 1 - 1 2 1 - - 2 60.60 40–72
HAM 2 3 - - - - 1 - - - - 18.00 5–70
PAP 16 18 11 3 3 - 2 - - - 4 16.87 .08–65
NEF 1 5 2 2 - - 2 - - - - 28.70 6–70
SCH - 1 - - - - - - - - 1 * *
MSA - 1 - - - - - - - - - * *
CEM - - 2 - - - - - - - - * *
CHSY - 1 - - - - - - - - - * *
REBA 1 - - - - - - - - - - * *
TOTAL 448 232 372 251 176 155 95 32 7 2 93